Four things to know:
1. The study, published in Pain Physician Journal, studied Discseel for treating chronic low back pain and sciatica, according to a news release.
2. The study of 725 individuals showed statistically significant improvement in all measured outcomes at 1-, 2- and 3-years after undergoing the procedure.
3. Patients enrolled in the study were eligible if they failed “a combination of at least four prior treatments including surgical fusion, laminectomy, discectomy, stem cell injection, and other invasive treatments,” Kevin Pauza, MD, the study’s lead investigator said in the release.
4. Discseel is an outpatient spine procedure that uses a Fibrin biologic drug to seal disc damage and stimulate growth.
